Komunikaty PR

Artificial Intelligence In Precision Medicine Market Forecasted to Reach $24.11 Billion by 2034, Growing at 18.48% CAGR

2025-04-14  |  12:55:05
Artificial Intelligence In Precision Medicine Market

Artificial Intelligence In Precision Medicine Market

AI accelerates the drug discovery process by analyzing complex biological data to identify potential drug candidates.

US, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Artificial Intelligence in the Precision Medicine Market

Introduction

Precision medicine is a rapidly evolving field that customizes healthcare treatment to individual characteristics such as genetics, environment, and lifestyle. As the healthcare industry continues to embrace technological innovations, Artificial Intelligence (AI) has emerged as a transformative force in precision medicine. AI enhances data analysis, disease prediction, drug discovery, and personalized treatment, paving the way for a new era in medical science.

The integration of AI in precision medicine is not just revolutionizing patient care but also unlocking a wealth of opportunities for stakeholders in the healthcare ecosystem—from tech companies and pharmaceuticals to diagnostics and clinical researchers.

Market Overview and Analysis

The global AI in precision medicine market share is experiencing rapid growth, driven by increasing adoption of AI technologies, the growing prevalence of chronic diseases, and the availability of massive volumes of patient data through electronic health records and genomic sequencing.

Get your copy now by clicking here:

https://www.marketresearchfuture.com/sample_request/29914

Market Size and Growth

The artificial intelligence (AI) in precision medicine market is expected to experience significant growth, with its value projected to increase from USD 5.24 billion in 2025 to USD 24.11 billion by 2034. This growth represents a robust compound annual growth rate (CAGR) of 18.48% during the forecast period from 2025 to 2034. Notably, the market was valued at USD 4.42 billion in 2024, highlighting the rapid expansion and rising adoption of AI technologies in the field of precision medicine.

Key Drivers

Rising demand for personalized healthcare

Expansion of genomics and big data analytics

Availability of large-scale healthcare datasets

Government initiatives promoting AI in healthcare

Increased investment in AI startups focused on healthcare solutions

Technological Advancements and Developments

AI technologies such as machine learning (ML), natural language processing (NLP), and deep learning are being deployed across multiple areas of precision medicine.

Some major advancements include:

Genomic Data Interpretation

AI is improving the interpretation of genomic data, helping clinicians understand gene variations that influence diseases. Tools like DeepVariant by Google use deep learning to accurately identify genetic mutations from sequencing data.

AI-Driven Diagnostics

AI models are aiding in faster and more accurate diagnosis of diseases such as cancer, Alzheimer’s, and cardiovascular conditions. For example, IBM Watson can analyze unstructured medical data and provide treatment recommendations based on evidence.

Personalized Treatment Plans

Using patient data, AI can predict how individuals will respond to different treatments. This enables doctors to choose the most effective therapy, minimizing side effects and improving outcomes.

Drug Discovery and Development

AI accelerates the drug discovery process by analyzing complex biological data to identify potential drug candidates. Companies like BenevolentAI and Insilico Medicine are pioneering AI-based drug development.

Buy it now by visiting here:

https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=29914

Key Companies in the Artificial Intelligence In Precision Medicine Market Include

Google
Intel
Novartis
Illumina
GSK
Microsoft
Qiagen
NVIDIA
Amazon Web Services
Pfizer
Agilent Technologies
IBM
Roche
Thermo Fisher Scientific

Artificial Intelligence In Precision Medicine Market Segmentation Insights

The artificial intelligence (AI) in precision medicine market is segmented across several key dimensions, reflecting its diverse applications and technological foundations. In terms of application, AI is utilized in drug discovery and development, disease diagnosis and prognosis, personalized treatment planning, biomarker discovery, and clinical trial optimization, showcasing its transformative impact on all stages of medical care and research. From a technology perspective, the market leverages machine learning, deep learning, natural language processing, computer vision, and big data analytics to drive innovation and improve outcomes.

The market is also categorized by type of data used, which includes genomic data, proteomic data, imaging data, electronic health records, and patient demographics, enabling highly personalized and data-driven approaches to medicine. In terms of indications, AI in precision medicine is applied to a wide range of medical fields such as oncology, neurology, genetics, immunology, and infectious diseases, emphasizing its broad clinical relevance.

Looking at end users, the key stakeholders include pharmaceutical and biotechnology companies, healthcare providers, research institutions, government organizations, and patients, each playing a vital role in the development and implementation of AI-driven solutions. Geographically, the market spans North America, Europe, South America, Asia Pacific, and the Middle East and Africa, highlighting its global reach and the widespread adoption of AI technologies in precision medicine across various healthcare ecosystems.

Future Business Opportunities

The AI in precision medicine market holds significant future business potential. Some key opportunities include:

AI-Powered Clinical Decision Support

Startups and established firms can develop AI-powered platforms that assist healthcare professionals with real-time decision-making, improving diagnostic accuracy and patient care.

Expansion into Emerging Markets

There is an untapped opportunity in developing regions where AI can help address resource limitations and improve healthcare accessibility through telemedicine and mobile health platforms.

AI-as-a-Service (AIaaS) for Healthcare

Tech companies can offer AI tools as cloud-based services, enabling smaller healthcare organizations to adopt precision medicine technologies without heavy upfront investments.

Collaborations and Ecosystem Development

Partnerships between tech companies, pharmaceutical firms, and healthcare providers can accelerate innovation and commercialization of AI-driven precision medicine solutions.

Integration with Wearables and IoT

Combining AI with health-monitoring wearables and Internet of Things (IoT) devices will enable continuous patient monitoring, early disease detection, and proactive interventions.

Challenges and Considerations

Despite the potential, the integration of AI in precision medicine is not without challenges:

Data privacy and security: Safeguarding patient data is critical, and regulations such as HIPAA and GDPR must be adhered to.

Interoperability: Seamless integration with existing healthcare systems is necessary for scalability.

Ethical and bias issues: AI algorithms must be transparent and free from biases that could impact healthcare outcomes.

Regulatory hurdles: Gaining regulatory approval for AI-based medical tools can be time-consuming and complex.

France Hearing Aids Market: https://www.marketresearchfuture.com/reports/france-hearing-aids-market-45301

Gcc Hearing Aids Market: https://www.marketresearchfuture.com/reports/gcc-hearing-aids-market-45302

Germany Hearing Aids Market: https://www.marketresearchfuture.com/reports/germany-hearing-aids-market-45299

India Hearing Aids Market: https://www.marketresearchfuture.com/reports/india-hearing-aids-market-45305

Italy Hearing Aids Market: https://www.marketresearchfuture.com/reports/italy-hearing-aids-market-45303

Japan Hearing Aids Market: https://www.marketresearchfuture.com/reports/japan-hearing-aids-market-45300

South America Hearing Aids Market: https://www.marketresearchfuture.com/reports/south-america-hearing-aids-market-45304

South Korea Hearing Aids Market: https://www.marketresearchfuture.com/reports/south-korea-hearing-aids-market-45298

Spain Hearing Aids Market: https://www.marketresearchfuture.com/reports/spain-hearing-aids-market-45307

Uk Hearing Aids Market: https://www.marketresearchfuture.com/reports/uk-hearing-aids-market-45297

Market Research Future
Market Research Future
+1 855-661-4441
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-04-15 | 20:55:05

A. R. Nightshade Unveils Groundbreaking Book on Modern Dating — A Must-Read for Singles Everywhere

Chronicles of Dating Disasters: The Shit You’re Doing Wrong! NEW YORK CITY, NY, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Acclaimed author A. R. Nightshade has officially launched Chronicles of Dating Disasters: The Shit
EIN Newswire BRAK ZDJĘCIA
2025-04-15 | 20:55:05

Touched by Type 1 Short Film Hannah’s Story Nominated for 2025 People’s Telly Award

25 Years of Touched by Type 1Touched by Type 1 Short Film Hannah’s Story Nominated for 2025 People’s Telly AwardThis nomination is more than recognition—it’s a celebration of every person living with Type 1 Diabetes and the
EIN Newswire BRAK ZDJĘCIA
2025-04-15 | 20:55:05

Minore's Meats, Inc. Aquired by J&M Vital Provisions, LLC

Touchstone Advisors Represents Minore’s Meats in the Sale of Their Third-generation Family Owned Food Distribution BusinessMinore's is a wonderful company that has been in business for over 100 years. We are proud to have assisted the

Kalendarium

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Szkolenie Online IMM

Prawo

400 gmin w Polsce nie ma na swoim terenie apteki i sytuacja co roku się pogarsza. Samorządowcy apelują o zmiany w prawie

W ciągu ostatnich kilku lat, od wejścia w życie przepisów Apteka dla Aptekarza, zamknięto ponad 2,2 tys. aptek w Polsce, a około 400 gmin nie posiada na swoim terenie apteki. Trzech na pięciu Polaków, aby kupić leki, musi się udać po nie do innej miejscowości. Sygnatariusze listu otwartego do minister zdrowia przygotowanego przez Koalicję „Na pomoc niesamodzielnym” apelują o zmianę priorytetów w legislacji dotyczącej rynku aptek. Wzywają też do podjęcia systemowych działań przeciwdziałających wykluczeniu zdrowotnemu ze względu na miejsce zamieszkania.

Bankowość

1 mln zł na innowacyjne rozwiązania dla miast. Granty mogą otrzymać naukowcy i start-upy

Niskoemisyjny transport, oszczędzanie zasobów, zarządzanie odpadami czy walka z zanieczyszczeniami – to część wyzwań, które stawia przed miastami szybko rosnąca liczba mieszkańców. Na przynajmniej część z nich odpowiedzią mogą być innowacje, które mogą pomóc także w adaptacji miast do zmiany klimatu. To właśnie innowacyjnych rozwiązań wspierających zrównoważony rozwój miast poszukuje ING Bank Śląski w nowej edycji Programu Grantowego. Do młodych naukowców i start-upów trafi 1 mln zł.

Telekomunikacja

Obciążenia regulacyjne uderzają w branżę nowych technologii i start-upy. To może hamować innowacje

Nadmierne obciążenia biurokratyczne i wysokie koszty prawne są wskazywane przez wiele start-upów jako bariery, które są najtrudniejsze do pokonania w ich działalności – wynika z raportu „Polskie Startupy 2024”. To sprawia, że część z nich szuka możliwości przeprowadzki za ocean – ze stratą dla innowacyjności i konkurencyjności polskiej gospodarki. Również w branży ICT o potrzebie deregulacji mówi się od lat, bo to przeszkadza jej w globalnym wyścigu technologicznym.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.